%0 Case Reports
%T Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation.
%A Zangmo U
%A Jayanna S
%A Shanmugam MP
%J Nepal J Ophthalmol
%V 15
%N 30
%D 2023 Jul
%M 38976342
暂无%R 10.3126/nepjoph.v15i2.55033
%X <B>BACKGROUND: </B>Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.<BR><B>METHODS: </B>We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.<BR><B>METHODS: </B>She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.<BR><B>CONCLUSIONS: </B>Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.